INIS
membranes
100%
phospholipids
100%
aggregation
100%
proteins
75%
human factors
75%
hemophilia
75%
electron microscopy
50%
administration
25%
patients
25%
humans
25%
increasing
25%
plasma
25%
therapy
25%
defects
25%
surfaces
25%
length
25%
glycoproteins
25%
dynamics
25%
distribution
25%
light scattering
25%
serine
25%
blood plasma
25%
suspensions
25%
dichroism
25%
bound state
25%
Biochemistry, Genetics and Molecular Biology
Immunogenicity
100%
Factor VIII
100%
Phospholipid Vesicle
100%
Membrane
16%
Haemophilia A
16%
Protein
11%
Pig
11%
Cryo-Electron Microscopy
11%
Development
5%
Length
5%
Glycoprotein
5%
Protein Secondary Structure
5%
Dynamic Light Scattering
5%
Cofactor
5%
Coagulation
5%
Circular Dichroism
5%
Phospholipid Membrane
5%
Blood Plasma
5%
Serine Protease
5%
Suspension
5%
Thrombocyte Activation
5%
Therapeutic Protein
5%
Thrombocyte Membrane
5%
Tenase
5%
Medicine and Dentistry
Immunogenicity
100%
Blood Clotting Factor 8
100%
Phospholipid Vesicle
100%
Protein
17%
Haemophilia A
17%
Therapeutic Procedure
11%
Cryoelectron Microscopy
11%
Development
5%
Patient
5%
Blood Proteins
5%
Coagulation
5%
Phospholipid Membrane
5%
Thrombocyte Activation
5%
Bleeding Disorder
5%
Blood Plasma
5%
Serine Proteinase
5%
Blood Clotting Factor 8 Concentrate
5%
Protein Secondary Structure
5%
Tenase
5%
Thrombocyte Membrane
5%
Photon Correlation Spectroscopy
5%
Circular Dichroism
5%
Immunology and Microbiology
Immunogenicity
100%
Factor VIII
100%
Phospholipid Vesicle
100%
Membrane
16%
Blood Plasma
11%
Pig
11%
Cryo-Electron Microscopy
11%
Development
5%
Length
5%
Glycoprotein
5%
Dynamics
5%
Light Scattering
5%
Suspension
5%
Protein Secondary Structure
5%
Thrombocyte Activation
5%
Phospholipid Membrane
5%
Thrombocyte Membrane
5%
Pharmacology, Toxicology and Pharmaceutical Science
Immunogenicity
100%
Phospholipid
100%
Blood Clotting Factor 8
100%
Protein
17%
Hemophilia A
17%
Pig
11%
Cryo-Electron Microscopy
11%
Plasma Protein
5%
Serine Proteinase
5%
Bleeding Disorder
5%
Blood Clotting Factor 8 Concentrate
5%
Dynamic Light Scattering
5%
Keyphrases
Vesicle Aggregation
100%
Micro Organizations
20%
Plasma-derived Factor VIII
20%
Structure Distribution
20%
Protein Therapeutics
20%
Vesicle Suspensions
20%
B-domain Deleted Recombinant Factor VIII
20%
Therapeutic Properties
20%